They are searching for existing drug repurposing ideas for rare diseases that have yet to receive a full clinical trial. Their primary aim is to demonstrate the huge potential of clinic-led, patient group-led, and researcher-driven innovation in drug repurposing for rare diseases, and the need for new funding streams to help these ideas bridge the translational gap, including Findacure’s Rare Disease Drug Repurposing Social impact Bond (RDDR SIB).
Ideal projects will have some form of collaborator in the UK (note: the PI is not required to be based in the UK), and multinational clinical trials are welcome. For additional eligibility criteria and further information >>>
Deadline for submissions: May, 31 2017
Since over 20 years the Swiss Paediatric Surveillance Unit (SPSU) - the national survey system to document rare paediatric pathologies and rare complications of more common diseases by children treated in hospitals in Switzerland - is a pillar stone in national surveillance. Through this network epidemiological questions were answered and new treatment regimens were found.
Pediatric researchers are kindly invited to use this network for their own study projects as it will support you via 33 participating hospitals, i.e. all pediatric clinics of Switzerland. Their return rate of questionnaires is always 100%!
For the conduct of your clinical study the infrastructure of SwissPedNet is at your disposal.
The objective of this call is to support the multinational extension of paediatric studies on medicinal products having already secured funding in the coordinating country.
Hence, if you have a protocol already accepted for funding in Switzerland but you need funding to go abroad, then this call is perfect for you!
All 18 member countries of the PedCRIN consortium are eligible.
Submission deadline: May 2, 2017 | 17.00h CET
On 4 January 2017 IMI (Innovative Medicines Initiative) launched its 10th call for submission of project proposals under the IMI 2 programme.
CONNECT4CHILDREN responds and is building a large, integrated, sustainable European Consortium of national networks, specialty networks and individual clinical sites liaising closely with industrial partners.
SwissPedNet is the Swiss partner in this consortium.
For all interested people: OPEN WEBINAR ON 2 MARCH 2017 | 14.00 CET TO PRESENT THE MAIN FEATURES OF THE PROPOSAL. Find all details in the Newsletter Issue 1 >>>
ECRIN has announced the launch of the Paediatric Clinical Research Infrastructure Network (PedCRIN).
The three-year project brings together ECRIN and the founding partners of the European Paediatric Clinical Trial Research Infrastructure (EPCT-RI) to develop capacity for the management of multinational paediatric clinical trials.
Beneficiary of this Horizon 2020 project in Switzerland is SwissPedNet, the Swiss hub of the EPCT-RI and PedCRIN.
Please find all information directly here >>>
The Nuffield Council, in collaboration with the Global Health Network, has produced a new online training course. The course is available in English and Spanish.
Available in English and Spanish, the course is aimed at researchers and members of ethics committees globally, to give them confidence in thinking through the challenges of carrying out research with children and young people. The course is free and open to anyone (though registration on the site is required), and takes 45-60 minutes to complete. A certificate is issued on successful completion.
This resource is based on the Council’s recent report which explores ethical issues around the involvement of children and young people in clinical research. It also draws on previous Council work on the ethics of healthcare research in developing countries.